Skip to content

Clinical trials

Phase 2 Coronary Artery Disease trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 2 Country / region: Germany Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20055
20063
20082
20091
20101
20111
20171
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status4
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
University of Leipzig2
University of Ulm2
Abbott Medical Devices1
Deutsches Herzzentrum Muenchen1
Dr. F. Köhler Chemie GmbH1
Gilead Sciences1
GlaxoSmithKline1
Johann Wolfgang Goethe University Hospital1
Ludwig-Maximilians - University of Munich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease18
Coronary Restenosis2
Coronary Stenosis2
Angina, Unstable1
Atherosclerosis1
Coronary Disease1
Diabetes Mellitus, Type 21
Heart Diseases1
Heart Failure, Diastolic1
Myocardial Infarction1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.